This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
ATGE vs. BFAM: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
ATGE vs. BFAM: Which Stock Is the Better Value Option?
Peloton (PTON) Expands Its Global Footprints With Partnerships
by Zacks Equity Research
Peloton (PTON) collabs with Amazon and Sport-Tiedje to expand its global footprints.
Choice Hotels (CHH) Faces Setback as Wyndham Rejects Buyout Bid
by Zacks Equity Research
Choice Hotels' (CHH) bid to acquire Wyndham (WH) at $90 per share, a mix of stock and cash, faces resolute rejection.
Vista Outdoor (VSTO) to Sell its Sporting Products Business
by Zacks Equity Research
Vista Outdoor (VSTO) inks a deal to sell its Sporting Products business. Given the challenging macro conditions, the company lowers its fiscal 2024 guidance.
Pool Corp. (POOL) Outruns Industry in a Year: More Room to Run?
by Zacks Equity Research
Pool Corp. (POOL) emphasizes expansion to drive revenue growth.
Is Adtalem Global Education (ATGE) Stock Outpacing Its Consumer Discretionary Peers This Year?
by Zacks Equity Research
Here is how Adtalem Global Education (ATGE) and Codere Online Luxembourg, S.A. (CDRO) have performed compared to their sector so far this year.
Zacks Industry Outlook Highlights Bright Horizons Family Solutions, Grand Canyon Education, Strategic Education, Adtalem Global Education and American Public Education
by Zacks Equity Research
Bright Horizons Family Solutions, Grand Canyon Education, Strategic Education, Adtalem Global Education and American Public Education are part of the Zacks Industry Outlook
American Public (APEI) to Gain From Affordable Online Programs
by Zacks Equity Research
American Public (APEI) is poised to benefit from affordable tuition, strategic initiatives and improved enrollment trends.
5 Stocks in the Booming Schools Industry for Enhanced Returns
by Shrabana Mukherjee
Virtual delivery of education, growing demand for healthcare professionals and prudent cost-saving initiatives are likely to open up opportunities for BFAM, LOPE, STRA, ATGE and APEI. The rapid advancement of generative AI and higher costs are risks.
ATGE or LOPE: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
ATGE vs. LOPE: Which Stock Is the Better Value Option?
Zacks.com featured highlights GeoPark, Build-A-Bear, AAR and Adtalem Global Education
by Zacks Equity Research
GeoPark, Build-A-Bear, AAR and Adtalem Global Education have been highlighted in this Screen of The Week article.
4 Stock to Buy as New Analysts Initiate Coverage
by Shrabana Mukherjee
The recent surge in analyst coverage for stocks such as GeoPark (GPRK), Build-A-Bear (BBW), AAR (AIR) and Adtalem (ATGE) indicates the potential for significant price appreciation in the near term.
Pick These 4 Low P/CF Stocks to Uplift Your Portfolio
by Sumit Singh
Value investing is essentially about selecting stocks that are usually cheap but fundamentally sound. Select Medical (SEM), EnerSys (ENS), Marathon Oil (MRO) and Adtalem Global (ATGE) boast a low P/CF ratio.
ATGE vs. UTI: Which Stock Is the Better Value Option?
by Zacks Equity Research
ATGE vs. UTI: Which Stock Is the Better Value Option?
Are Consumer Discretionary Stocks Lagging Adtalem Global Education (ATGE) This Year?
by Zacks Equity Research
Here is how Adtalem Global Education (ATGE) and Central Garden (CENTA) have performed compared to their sector so far this year.
Adtalem (ATGE) & DaVita to Launch Nephrology Nursing Course
by Zacks Equity Research
Adtalem (ATGE) collaborates with DaVita to prepare nursing students for nephrology careers.
Are Investors Undervaluing Adtalem Global Education (ATGE) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Adtalem (ATGE) Is a Great Choice for 'Trend' Investors, Here's Why
by Zacks Equity Research
Adtalem (ATGE) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
Adtalem (ATGE) Outpaces Industry YTD: More Upside Left?
by Zacks Equity Research
Adtalem's (ATGE) emphasis on strategic collaboration & innovation and cost synergies will likely aid its long term growth strategy.
ATGE vs. UTI: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
ATGE vs. UTI: Which Stock Is the Better Value Option?
Culp's (CULP) Q1 Earnings Beat Estimates, Revenues Miss
by Zacks Equity Research
Culp's (CULP) fiscal first-quarter 2024 results reflect tepid segmental performances attributable to housing demand softness and risky macroenvironment. Nonetheless, margin expansion and no outstanding debt partially counterbalanced the quarter.
Culp (CULP) to Report Strong Q1 Earnings: Factors to Note
by Zacks Equity Research
Operating efficiencies, a favorable product mix and lower costs are likely to have boosted Culp's (CULP) fiscal Q1 performance.
Should Value Investors Buy Adtalem Global Education (ATGE) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
What's in Store for American Woodmark (AMWD) in Q1 Earnings?
by Zacks Equity Research
American Woodmark's (AMWD) Q1 earnings are likely to have benefited from pricing actions and operational improvements.
Sphere (SPHR) Q4 Earnings Surpass Estimates, Revenues Miss
by Zacks Equity Research
Sphere's (SPHR) fiscal fourth-quarter 2023 reports reflect decline in revenues, driven by dismal MSG networks segment performance, and increased direct operating expenses.